metreleptin sold brand name myalept among others synthetic analog hormone leptin used treat various forms dyslipidemia approved japan metabolic disorders including lipodystrophy united states replacement therapy treat complications leptin deficiency addition diet patients congenital generalized acquired generalized common side effects include hypoglycaemia low blood glucose weight european union metreleptin indicated addition diet treat lipodystrophy people loss fatty tissue skin buildup fat elsewhere body liver muscles used adults children age two years generalised lipodystrophy berardinelliseip syndrome lawrence syndrome adults children age twelve years partial lipodystrophy including barraquersimons syndrome standard treatments united states indicated adjunct diet replacement therapy treat complications leptin deficiency people congenital acquired generalized metreleptin currentlywhen investigated treatment diabetes andor hypertriglyceridemia patients rare forms lipodystrophy syndromes characterized abnormalities adipose tissue distribution severe metabolic fda approved metreleptin injection treating complications leptin deficiency february citation needed threeyear study metreleptin patients lipodystrophy organized national institute diabetes digestive kidney diseases national institutes health metreleptin treatment associated significant decrease blood glucose decreased baseline study end triglyceride concentration mgdl baseline mgdl study metreleptin effective patients generalized lipodystrophy circulating leptin levels extremely low analogous insulin replacement patients type diabetes metreleptin restores function deficient hormone however patients partial lipodystrophy relative leptin deficiency response metreleptin may may due antileptin antibodies nhs england commission metreleptin treatment patients ages congenital leptin deficiency april metreleptin currently researched potential benefit treatment anorexia hypothesized gradual loss body fat mass specifically ensuing low leptin levels escalate preexisting drive thinness obsessivecompulsivelike addictivelike state shown shortterm metreleptin treatment patients anorexia nervosa rapid onset beneficial cognitive emotional behavioral among things depression drive activity repetitive thoughts food inner restlessness weight phobia decreased rapidly whether metreleptin another leptin analogue suitable treatment anorexia nervosa remains seen potential side effects weight loss development antimetreleptin antibodies clinical study metreleptin treatment improved nonalcoholic steatohepatitis fatty liver disease patients partial lipodystrophy relative leptin deficiency steatosis hepatic injury scores metreleptin reduces body weight overweight people low leptin although effective weight loss drug leptin levels lowered people lost weight hypothesized supplemental leptin could help weight loss maintenance however currently regulatory pathway drug approval httpsenwikipediaorgwikimetreleptin